FN1 promotes invasion of RCC via YWHAZ-associated signaling with partial involvement of the PI3K-Akt pathway
- 1Department of Urology, General Hospital of Ningxia Medical University
Abstract
Purpose: Clear cell renal cell carcinoma (ccRCC) accounts for more than 75% of renal cell carcinomas and is characterized by high metastatic potential and resistance to therapy. Fibronectin 1 (FN1), a major extracellular matrix glycoprotein, is overexpressed in various cancers and promotes tumor progression; however, its precise molecular mechanisms in RCC remain unclear.
Methods: We analyzed the expression level of FN1 and its clinical relevance in ccRCC using TCGA database. Subsequently, FN1 was knocked down in ACHN cells, followed by functional assays, RNA sequencing, and Western blot validation. Furthermore, we integrated FN1-interacting proteins from the BioGRID and STRING databases and combined this information with differentially expressed genes to identify key downstream effectors of FN1.
Results: FN1 was significantly upregulated in ccRCC and strongly associated with lymph node metastasis, distant metastasis, and poor overall survival. FN1 knockdown markedly suppressed invasion of ACHN cells, induced transcriptomic alterations, and downregulated key oncogenes, including CSF2, SOX9, and LAMC2. Pathway analysis revealed significant inhibition of the PI3K–Akt signaling axis. Integrating FN1-interacting proteins with the DEGs identified YWHAZ—a known regulator of the PI3K–Akt pathway—as a critical downstream effector of FN1, whose expression was markedly reduced upon FN1 knockdown. Rescue experiments further showed that YWHAZ overexpression substantially restored FN1 knockdown-impaired invasion but only modestly and non-significantly affected Akt phosphorylation.
Conclusion: FN1 promotes invasion in RCC cells at least in part through YWHAZ-dependent mechanisms, with partial involvement of PI3K-Akt signaling and additional pathways likely contributing. These findings suggest that the FN1/YWHAZ axis may serve as a candidate prognostic marker and a potential target for future preclinical investigation in RCC.
Related
- Extracellular adenosine triphosphate upregulates S100A4 expression and promotes the migration and invasion of breast cancer cells via P2Y2/SOX9 signaling
- Gap Junction Protein Connexin43 (Cx43) Promotes Glioma Invasion via the Annexin A2/MMP3 Signaling Axis
- JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway
- Chronic exposure to the tire-wear contaminant 6-PPDQ induces senescence-associated biomarkers and neurobehavioral deficits: Involvement of ABL1-p53-autophagy signaling
- Macrostemonoside I alleviates metabolic dysfunction-associated steatotic liver disease in mice: potential involvement of SCAP/SREBP2 signaling in cholesterol metabolism.
BibTeX
@article{zhang2026promotes,
title = {{FN1 promotes invasion of RCC via YWHAZ-associated signaling with partial involvement of the PI3K-Akt pathway}},
author = {Chao Zhang and Yu Gao and Tao Yang and Zheng Feng and Chunmei Ma and Lingdong Lv and Feilong Yang and Zhiyong Lv},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1974418},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1974418/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - FN1 promotes invasion of RCC via YWHAZ-associated signaling with partial involvement of the PI3K-Akt pathway
AU - Chao Zhang
AU - Yu Gao
AU - Tao Yang
AU - Zheng Feng
AU - Chunmei Ma
AU - Lingdong Lv
AU - Feilong Yang
AU - Zhiyong Lv
PY - 2026
DA - 2026/10/14
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1974418
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1974418/full
AB - Purpose: Clear cell renal cell carcinoma (ccRCC) accounts for more than 75% of renal cell carcinomas and is characterized by high metastatic potential and resistance to therapy. Fibronectin 1 (FN1), a major extracellular matrix glycoprotein, is overexpressed in various cancers and promotes tumor progression; however, its precise molecular mechanisms in RCC remain unclear. Methods: We analyzed the expression level of FN1 and its clinical relevance in ccRCC using TCGA database. Subsequently, FN1 was knocked down in ACHN cells, followed by functional assays, RNA sequencing, and Western blot validation. Furthermore, we integrated FN1-interacting proteins from the BioGRID and STRING databases and combined this information with differentially expressed genes to identify key downstream effectors of FN1. Results: FN1 was significantly upregulated in ccRCC and strongly associated with lymph node metastasis, distant metastasis, and poor overall survival. FN1 knockdown markedly suppressed invasion of ACHN cells, induced transcriptomic alterations, and downregulated key oncogenes, including CSF2, SOX9, and LAMC2. Pathway analysis revealed significant inhibition of the PI3K–Akt signaling axis. Integrating FN1-interacting proteins with the DEGs identified YWHAZ—a known regulator of the PI3K–Akt pathway—as a critical downstream effector of FN1, whose expression was markedly reduced upon FN1 knockdown. Rescue experiments further showed that YWHAZ overexpression substantially restored FN1 knockdown-impaired invasion but only modestly and non-significantly affected Akt phosphorylation. Conclusion: FN1 promotes invasion in RCC cells at least in part through YWHAZ-dependent mechanisms, with partial involvement of PI3K-Akt signaling and additional pathways likely contributing. These findings suggest that the FN1/YWHAZ axis may serve as a candidate prognostic marker and a potential target for future preclinical investigation in RCC.
SN - 2234-943X
ER -